Bausch Health Co. Inc. (BHC) Misses Q4 EPS by 151c; offers guidance

Bausch Health Co. Inc. (NYSE: BHC) reported Q4 EPS of ($0.30), $1.51 worse than the analyst estimate of $1.21. Revenue for the quarter came in at $2.8 billion versus the consensus estimate of $2.71 billion.

GUIDANCE:

Bausch Health Co. Inc. sees FY2026 revenue of $10.625-10.875 billion, versus the consensus of $10.517 billion.

For earnings history and earnings-related data on Bausch Health Co. Inc. (BHC) click here.

You May Also Be Interested In

• Cerebras Systems (CBRS) Misses Q1 EPS, Revenues Beat
• Bernstein SocGen Group Reiterates Outperform Rating on Hermes International (RMS:FP) (HESAY) after cautious commentary
• Enanta Pharma loses appeal in Pfizer Paxlovid patent case